JAZZ PHARMACEUTICALS PLC (JAZZ)       154.5  +1.5 (+0.98%)

154.5  +1.5 (+0.98%)

IE00B4Q5ZN47 - Common Stock

Buy % Consensus

Analysts have set a mean price target of 202.98. This target is 31.38% above the current price.
JAZZ was analyzed by 24 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about JAZZ.
In the previous month the buy percentage consensus was at a similar level.
JAZZ was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 154.50171.70200.43202.98252.00 - 11.13% 29.73% 31.38% 63.11%

Up and Down Grades

Date Firm Action Rating
2022-11-10 Needham Maintains Buy
2022-11-10 RBC Capital Maintains Outperform
2022-11-10 Goldman Sachs Maintains Neutral
2022-09-29 Goldman Sachs Maintains Neutral
2022-09-21 Goldman Sachs Maintains Neutral
2022-08-04 BMO Capital Maintains Outperform
2022-08-04 UBS Maintains Buy
2022-08-04 SVB Leerink Maintains Outperform
2022-08-04 Morgan Stanley Maintains Equal-Weight
2022-06-14 UBS Initiate Buy
2022-05-05 RBC Capital Maintains Outperform
2022-05-05 Piper Sandler Maintains Overweight
2022-03-03 HC Wainwright & Co. Maintains Buy
2022-03-02 RBC Capital Maintains Outperform
2022-03-02 Piper Sandler Maintains Overweight
2021-12-20 SVB Leerink Maintains Outperform
2021-12-17 Needham Maintains Buy
2021-10-08 Morgan Stanley Maintains Equal-Weight
2021-10-05 Citigroup Initiate Buy
2021-09-23 Needham Initiate Buy
2021-08-16 HC Wainwright & Co. Maintains Buy
2021-06-22 Barclays Maintains Overweight
2021-06-21 HC Wainwright & Co. Maintains Buy
2021-06-18 SVB Leerink Maintains Outperform
2021-05-17 HC Wainwright & Co. Maintains Buy
2021-04-14 Stifel Maintains Buy
2021-04-01 Morgan Stanley Maintains Equal-Weight
2021-03-01 UBS Maintains Buy
2021-02-24 SVB Leerink Maintains Outperform
2021-02-24 Piper Sandler Maintains Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA